低氧誘導(dǎo)因子2α(HIF2a)重組蛋白
Recombinant Hypoxia Inducible Factor 2 Alpha (HIF2a)
EPAS1; HLF; MOP2; PASD2; BHLHE73; Endothelial PAS Domain 1; HIF-1 Alpha-Like Factor; Basic-helix-loop-helix-PAS protein MOP2; Class E basic helix-loop-helix protein 73
- 編號(hào)RPD466Mu01
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位細(xì)胞核
- 預(yù)測(cè)分子量37.2kDa
- 實(shí)際分子量37kDa(差異分析請(qǐng)參閱說明書)
- 片段與標(biāo)簽Asp21~Cys336 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)6.4
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1046 ¥ 2616 ¥ 5232 ¥ 15696 ¥ 39240
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. Gene Sequencing (Extract)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月，-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPD466Mu02 | 低氧誘導(dǎo)因子2α(HIF2a)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPD466Mu01 | 低氧誘導(dǎo)因子2α(HIF2a)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAD466Mu01 | 低氧誘導(dǎo)因子2α(HIF2a)多克隆抗體 | WB; IHC; ICC; IP. |
| PAD466Mu02 | 低氧誘導(dǎo)因子2α(HIF2a)多克隆抗體 | WB; IHC; ICC; IP. |
| LAD466Mu71 | 低氧誘導(dǎo)因子2α(HIF2a)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| SED466Mu | 低氧誘導(dǎo)因子2α(HIF2a)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMD466Mu | 低氧誘導(dǎo)因子2α(HIF2a)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Neuro Oncol | Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling [PubMed: 26409567] |
| Clinical Trials in Degenerative Diseases | Correlating oxidative stress-related factors with bone metabolic markers in older adult male patients exhibiting degenerative osteoporosis in the high-altitude hypoxic area of China: study protocol for a non-randomized controlled trial [issn:2542-3975] |
| Journal of Physiological Anthropology | Telomere elongation protects heart and lung tissue cells from fatal damage in rats exposed to severe hypoxia [Pubmed:29454386] |
| Oxidative damage and iron dyshomeostasis in thalassemic patients [] | |
| Neuropsychiatric Disease and Treatment | The Association Between Hypoxia Improvement and Electroconvulsive Therapy for Major Depressive Disorder [34588778] |
留言咨詢
